VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update
A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark
VolitionRx Limited's Triage Test Results Validated in Prospective Trial
VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference
VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017
VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia
VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe
VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference
VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference
VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016
